Nasdaq-listed MEI Pharma has officially acquired 929,548 Litecoin (LTC) for approximately $100 million. The average purchase price was $107.58 per LTC. This strategic investment marks MEI Pharma as the first publicly traded US company to directly invest in Litecoin. This move follows MEI Pharma's prior announcement last month indicating their intention to allocate $100 million to Litecoin. The investment signals increasing institutional interest in cryptocurrency beyond Bitcoin and Ethereum, highlighting Litecoin's potential as a store of value and medium of exchange. Investors will be watching MEI Pharma's performance closely to see if this Litecoin investment proves beneficial for the company's bottom line and stock performance. The announcement could trigger more companies to consider crypto diversification. ```

#BTC #ETH